John-Paul Jimenez - Concepedia

Author

John-Paul Jimenez

Also Known As

J P Díaz Jiménez, J.P. Jimenez, Jimenez, J.P., John-Paul Jimenez

107

Publications

474

Citations

H-Index

Concepts

All Affiliations

John-Paul Jimenez is an author at Synta Pharmaceuticals (United States).

John-Paul Jimenez

Publications

471

Citations

H-Index

Page 1

	Year	Citations
Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in <i>In Vitro</i> and <i>In Vivo</i> Models of Non–Small Cell Lung Cancer Takeshi Shimamura, Samanthi A. Perera, Kevin P. Foley, Clinical Cancer Research	2012	165
Overcoming Acquired BRAF Inhibitor Resistance in Melanoma via Targeted Inhibition of Hsp90 with Ganetespib Jaime Acquaviva, Donald L. Smith, John-Paul Jimenez, Molecular Cancer Therapeutics	2014	99
FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism Jaime Acquaviva, Suqin He, Chaohua Zhang, Molecular Cancer Research	2014	75
Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer David A. Proia, Chaohua Zhang, Manuel Sequeira, Clinical Cancer Research	2013	62
The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer Donald L. Smith, Jaime Acquaviva, Manuel Sequeira, Targeted Oncology	2014	37
HSP90 Inhibitor–SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors David A. Proia, Donald L. Smith, Junyi Zhang, Molecular Cancer Therapeutics	2015	33

Page 1